Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer

Biomarkers of response are needed in breast cancer to stratify patients to appropriate therapies and avoid unnecessary toxicity. We used peripheral blood gene expression and cell-type abundance to identify biomarkers of response and recurrence in neoadjuvant chemotherapy–treated patients with breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Axelrod, Margaret L., Wang, Yu, Xu, Yaomin, Sun, Xiaopeng, Bejan, Cosmin A., Gonzalez-Ericsson, Paula I., Nunnery, Sara, Bergman, Riley E., Donaldson, Joshua, Guerrero-Zotano, Angel L., Massa, Chiara, Seliger, Barbara, Sanders, Melinda, Mayer, Ingrid A., Balko, Justin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604512/
https://www.ncbi.nlm.nih.gov/pubmed/36304942
http://dx.doi.org/10.1158/2767-9764.CRC-22-0023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604512/
https://www.ncbi.nlm.nih.gov/pubmed/36304942
http://dx.doi.org/10.1158/2767-9764.CRC-22-0023

Ejemplares similares